CN104547721A - Traditional Chinese medicine for treating cholecystitis - Google Patents
Traditional Chinese medicine for treating cholecystitis Download PDFInfo
- Publication number
- CN104547721A CN104547721A CN201510060111.6A CN201510060111A CN104547721A CN 104547721 A CN104547721 A CN 104547721A CN 201510060111 A CN201510060111 A CN 201510060111A CN 104547721 A CN104547721 A CN 104547721A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- cholecystitis
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention relates to the field of pharmaceutical formulations and in particular relates to a traditional Chinese medicine for treating cholecystitis. The traditional Chinese medicine is characterized by being prepared from the following raw material medicines in parts by weight: 77-87 parts of serrate rabdosia herb, 41-51 parts of nauclea officinalis, 25-35 parts of aeluropus littoralis, 33-43 parts of aculeate staff tree, 25-35 parts of glossy privet fruit, 18-28 parts of felwort, 21-31 parts of avicennia pricklyash root, 19-29 parts of Heterohairy Monkshood Root, 14-24 parts of garden burnet, 20-30 parts of akebiaquinata, 13-23 parts of dayflower, 16-26 parts of raspberry, 10-20 parts of equisetum pretense, 37-47 parts of sophora fruit, 24-34 parts of buerger raspberry root, 26-36 parts of abrus cantoniensis hance, 8-18 parts of fruit of princesplume ladysthumb and 6-16 parts of caulis bambusae in taeniam. The preparation method comprises the following steps: mixing the raw material medicines, soaking by using water, decocting, and removing the decoction dregs, thereby obtaining the filtrate. The traditional Chinese medicine disclosed by the invention is short in course of treatment, fast in effectiveness, safe and non-toxic, does not have any side effect, is exact in curative effect of treating cholecystitis, can be used for improving the symptoms and alleviate pain of patients and can be widely applied to clinical treatment of the cholecystitis.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of Chinese medicine for the treatment of cholecystitis.
Background technology
As everyone knows, cholecystitis is a kind of common clinical, frequently-occurring disease, has that the course of disease is long, the feature of recurrent exerbation, and modern medicine thinks the many infection due to antibacterial and virus of cholecystitis, and obstruction of bile duct or pancreatic juice cause to multiple chemical factors such as biliary tract reflux.Along with people's living standard improves day by day, the change of dietary structure and the increase of job and life stress, the sickness rate of primary disease is in rising trend.Cholecystitis has become one of principal disease affecting human health.
Summary of the invention
Object of the present invention is exactly to overcome above-mentioned existing technical deficiency, provides a kind of Chinese medicine for the treatment of cholecystitis, short treating period instant effect, safe without toxic side effect, treatment cholecystitis determined curative effect, can symptom be improved, alleviate patient suffering, the clinical treatment of cholecystitis can be widely used in.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of Chinese medicine for the treatment of cholecystitis, it is characterized in that being made up of the crude drug of following weight portion, Herba Rabdosiae Lophanthoidis 77 ~ 87, Lignum et Radix Naucleae 41 ~ 51, Herba Aeluropi sinensis 25 ~ 35, Celastrus aceleatus Merr 33 ~ 43, Fructus Ligustri Lucidi 25 ~ 35, Radix Gentianae 18 ~ 28, Radix Zanthoxyli Avicennae 21 ~ 31, Radix Aconiti Heterotrichi 19 ~ 29, Radix Sanguisorbae 14 ~ 24, Caulis Akebiae 20 ~ 30, Herba Commelinae 13 ~ 23, Fructus Rubi 16 ~ 26, Equisetum pratense 10 ~ 20, the Fructus Sophorae 37 ~ 47, Radix rubi buergeri 24 ~ 34, Herba Abri 26 ~ 36, Fructus Polygoni Orientalis 8 ~ 18, Caulis Bambusae In Taenia 6 ~ 16, be soaked in water after above-mentioned raw materials medicine is mixed, to remove slag after decocting to obtain filtrate.
The invention has the beneficial effects as follows, short treating period instant effect, safe without toxic side effect, treatment cholecystitis determined curative effect, can improve symptom, alleviate patient suffering, can be widely used in the clinical treatment of cholecystitis.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1: the present embodiment adopts Herba Rabdosiae Lophanthoidis, Lignum et Radix Naucleae, Herba Aeluropi sinensis, Celastrus aceleatus Merr, Fructus Ligustri Lucidi, Radix Gentianae, Radix Zanthoxyli Avicennae, Radix Aconiti Heterotrichi, Radix Sanguisorbae, Caulis Akebiae, Herba Commelinae, Fructus Rubi, Equisetum pratense, the Fructus Sophorae, Radix rubi buergeri, Herba Abri, Fructus Polygoni Orientalis, Caulis Bambusae In Taenia to be that crude drug is prepared from.Its crude drug composition (weight portion) often takes as Herba Rabdosiae Lophanthoidis 82, Lignum et Radix Naucleae 46, Herba Aeluropi sinensis 30, Celastrus aceleatus Merr 38, Fructus Ligustri Lucidi 30, Radix Gentianae 23, Radix Zanthoxyli Avicennae 26, Radix Aconiti Heterotrichi 24, Radix Sanguisorbae 19, Caulis Akebiae 25, Herba Commelinae 18, Fructus Rubi 21, Equisetum pratense 15, the Fructus Sophorae 42, Radix rubi buergeri 29, Herba Abri 31, Fructus Polygoni Orientalis 13, Caulis Bambusae In Taenia 11.Get above-mentioned 18 kinds of crude drug, gross mass is 250g, at room temperature Chinese herbal medicine is added water to 900-1000ml, soak 4 hours, then boil slow fire with high heat and decoct to about 100-120 minute, remove slag to obtain filtrate about 200ml, medicinal residues add water 300-400ml again, decoct 30-40 minute, remove slag to obtain filtrate about 100ml, decocts medicine soup about 300ml for twice altogether.Every day, potion was oral at twice, each (medicine) being taken before meal about 150ml.
Herba Rabdosiae Lophanthoidis of the present invention has effect of clearing away heat-damp and promoting diuresis, jaundice eliminating damp eliminating, cool the blood dissipate blood stasis, is used for the treatment of acute icterohepatitis, acute cholecystitis; Lignum et Radix Naucleae can treat heat-clearing and toxic substances removing, reducing swelling and alleviating pain.Treating acute tonsillitis, pharyngolaryngitis, mastitis, enteritis, bacillary dysentery, urinary tract infection, cholecystitis; Herba Aeluropi sinensis has the function of clearing away heat and promoting diuresis.For icterohepatitis, the diseases such as gallbladder wing inflammation and cirrhotic ascites; Celastrus aceleatus Merr damp-clearing pain-relieving, damp eliminating function of gallbladder promoting, suppressing the hyperactive liver and subsiding YANG; Fructus Ligustri Lucidi is used for the poor vision of the hepatic and renal YIN deficiency, visual deterioration, early whitening of beard and hair, soreness of waist tinnitus and fever due to yin deficiency etc.; Radix Gentianae heat clearing and damp drying, eliminating pathogen in the liver is calmed the frightened.Jaundice due to damp-heat, urine leaching pain; Radix Zanthoxyli Avicennae controls laryngopharynx swelling and pain, general edema with yellowish skin, malaria, rheumatic ostalgia; Radix Aconiti Heterotrichi expelling wind and removing dampness, promoting blood circulation and stopping pain; The effects such as Radix Sanguisorbae has cooling blood for hemostasis, heat-clearing and toxic substances removing, trains clear yin nourishing, detumescence sore; Caulis Akebiae is used for stranguria, edema, vexed dark coloured urine, aphtha of the mouth and tongue, and amenorrhea breast is few, damp and hot arthralgia pain; The capable water of Herba Commelinae, heat clearing away, removing heat from blood, removing toxic substances.Harness the river swollen, beriberi, dysuria, flu, erysipelas, parotitis; Fructus Rubi the liver and the kidney tonifying, controlling nocturnal emission with astringent drugs reducing urination, improving eyesight; Equisetum pratense is invigorated blood circulation, diuresis, anthelmintic; Fructus Sophorae parasite killing removes wind, and improving eyesight is except hot tears, and between brains ambition, hot blast is unhappy, and dizziness due to wind pathogen is for falling; Radix rubi buergeri heat-clearing and toxic substances removing, promoting blood circulation and stopping pain.To treat for stomachache acid regurgitation, icterohepatitis; Herba Abri has dampness removing jaundice eliminating, heat-clearing and toxic substances removing, effect of dispersing the depressed liver-QI for alleviating pain; Fructus Polygoni Orientalis heat clearing away, softening the hard mass.For abdominal mass, the tuberculosis of cervical lymph nodes, diabetes; Caulis Bambusae In Taenia removing heat-phlegm, relieves restlessness and prevents vomiting.
The each raw material of the present invention also can the embodiment of part by weight mixing listed by according to the form below realize.Its processing technique is identical with embodiment 1.(unit: weight portion)
Embodiment | Herba Rabdosiae Lophanthoidis | Lignum et Radix Naucleae | Herba Aeluropi sinensis | Celastrus aceleatus Merr | Fructus Ligustri Lucidi | Radix Gentianae | Radix Zanthoxyli Avicennae | Radix Aconiti Heterotrichi | Radix Sanguisorbae | Caulis Akebiae | Herba Commelinae | Fructus Rubi | Equisetum pratense | The Fructus Sophorae | Radix rubi buergeri | Herba Abri | Fructus Polygoni Orientalis | Caulis Bambusae In Taenia |
Two | 77 | 51 | 25 | 43 | 25 | 28 | 21 | 29 | 14 | 30 | 13 | 26 | 10 | 47 | 24 | 36 | 8 | 16 |
Three | 87 | 41 | 35 | 33 | 35 | 18 | 31 | 19 | 24 | 20 | 23 | 16 | 20 | 37 | 34 | 26 | 18 | 6 |
Four | 80 | 46 | 31 | 38 | 30 | 26 | 22 | 21 | 16 | 26 | 18 | 18 | 19 | 37 | 28 | 30 | 16 | 14 |
The clinical trial carried out below in conjunction with my institute is described in further detail the present invention:
1 data and method
1.1 physical data
Select cholecystitis 90 example that the Gastroenterology dept.'s outpatient service of 2012-2013 hospital and in-patient department are gone to a doctor, all meet " new Chinese medicine guideline of clinical investigations " and determine diagnosis.Inclusive criteria: the patient meeting chronic cholecystitis diagnosis and Standards of Chinese Medical Syndrome Differentiation, can include test case in.Exclusion standard: (1) does not meet inclusive criteria; (2) discomforts such as the side of body rib distension pain of being brought out by the factor such as Drug or other diseases.(3) merge intentionally, the serious disease such as brain, lung, kidney.(4) gestation or women breast-feeding their children, those who are allergic to this drug.(5) severe cholecystitis: acute suppuration cholecystitis, acute gangrenous cholecystitis, acute obstructive suppurative cholangitis, the concurrent diffuse peritonitis person of perforation of gallbladder.(6) take other similar drugs person simultaneously.
Treatment group 60 example, come off 1 example, totally 59 example, male 31 example, women 28 example, 18-29 year 12 people, 30-49 year 28 people, 50-65 year 19 people, patient course of disease <1 10 people, 1-5 30 people, 5-10 19 people;
Matched group 30 example, come off 2 example, totally 28 example, wherein male 15 example, women 13 example, 18-29 year 5 people, 30-49 year 13 people, 50-65 year 10 people, patient course of disease <1 4 people, 1-5 14 people, 5-10 10 people.Three groups of case physical data (sex, age, the course of disease) comparing difference not statistically significants.
1.2 Therapeutic Method
Treatment group oral Chinese medicine composition one (preparing with reference to embodiment 1), every day, potion was oral at twice, each (medicine) being taken before meal about 150ml; The oral DANNING PIAN of matched group (being produced by Shanghai and xanthate industry), 5 tablets/time, every day three times.Treat 8 weeks.Period in a medicine avoids greasy, irritative food, work and rest rule.
1.3 observation index and method
1.3.1 clinical symptoms integral estimation: carry out a clinical symptoms integral estimation before treatment, once in a week rear.
1.3.2 lab index: hematuria stool routine, electrocardiogram, B ultrasonic and ALT, serum creatinine.Before treatment, once, rear every surrounding carries out ALT, serum creatinine inspection to contained item inspection, terminates rear check hematuria stool routine, electrocardiogram and B ultrasonic the course for the treatment of.B ultrasonic result before and after contrast therapy, observes the change of calculus size, gall-bladder wall thickness.
1.4 criterion of therapeutical effect
Formulate with reference to " new Chinese medicine clinical research principle ".Recovery from illness: after terminating the course for the treatment of, symptom and sign disappear, ultrasound diagnosis gallbladder volume and wall thickness normal; Effective: after terminating the course for the treatment of, symptom integral reduces 2 grades, and ultrasound diagnosis gallbladder volume and wall thickness obviously improve; Effective: after terminating the course for the treatment of, symptom integral reduces 1 grade, and ultrasound diagnosis gallbladder volume and wall thickness are improved; Invalid: not reach above-mentioned standard person, ultrasound diagnosis gallbladder volume still increases, wall thickness, crude.
1.5 statistical method
Adopt SPSS15.0 statistical software to carry out computational analysis, measurement data adopts t inspection, and enumeration data adopts X 2 test, and P<0.05 is that difference has statistical significance.
2 results
Clinical efficacy after 2.1 therapeutic evaluation treatment groups and treatment of control group is through statistical analysis, and the Different therapeutical effect of two groups has statistical significance (P<0.05), and treatment group is better than matched group (table 1).
Following table is the comparison [example (%)] of clinical efficacy
Group | Number of cases | Effective | Effectively | Invalid | Total effective rate (%) |
Treatment group | 59 | 41(70.0) | 15(24.8) | 3(5.2) | 94.8 |
Matched group | 28 | 15(55.8) | 7(23.6) | 6(20.6) | 79.4 |
2.2 untoward reaction: two groups all do not occur untoward reaction at treatments period.
Claims (1)
1. treat the Chinese medicine of cholecystitis for one kind, it is characterized in that: be made up of the crude drug of following weight portion, Herba Rabdosiae Lophanthoidis 77 ~ 87, Lignum et Radix Naucleae 41 ~ 51, Herba Aeluropi sinensis 25 ~ 35, Celastrus aceleatus Merr 33 ~ 43, Fructus Ligustri Lucidi 25 ~ 35, Radix Gentianae 18 ~ 28, Radix Zanthoxyli Avicennae 21 ~ 31, Radix Aconiti Heterotrichi 19 ~ 29, Radix Sanguisorbae 14 ~ 24, Caulis Akebiae 20 ~ 30, Herba Commelinae 13 ~ 23, Fructus Rubi 16 ~ 26, Equisetum pratense 10 ~ 20, the Fructus Sophorae 37 ~ 47, Radix rubi buergeri 24 ~ 34, Herba Abri 26 ~ 36, Fructus Polygoni Orientalis 8 ~ 18, Caulis Bambusae In Taenia 6 ~ 16, be soaked in water after above-mentioned raw materials medicine is mixed, to remove slag after decocting to obtain filtrate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510060111.6A CN104547721A (en) | 2015-02-05 | 2015-02-05 | Traditional Chinese medicine for treating cholecystitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510060111.6A CN104547721A (en) | 2015-02-05 | 2015-02-05 | Traditional Chinese medicine for treating cholecystitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104547721A true CN104547721A (en) | 2015-04-29 |
Family
ID=53065492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510060111.6A Pending CN104547721A (en) | 2015-02-05 | 2015-02-05 | Traditional Chinese medicine for treating cholecystitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104547721A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105233162A (en) * | 2015-10-30 | 2016-01-13 | 王志勇 | Traditional Chinese medicine composition for treating chronic cholecystitis, and preparation method and pharmaceuticals thereof |
CN106107036A (en) * | 2016-06-28 | 2016-11-16 | 宿松飞翔生态养殖有限公司 | A kind of livestock fodder additives with epidemic prevention function |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103230566A (en) * | 2013-04-19 | 2013-08-07 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medical composition for treating cholecystitis cholelithiasis and application thereof |
CN103495061A (en) * | 2013-09-25 | 2014-01-08 | 周志坚 | Traditional Chinese medicine composition for treating cholecystitis caused by stagnation of liver qi and phlegm and blood stasis |
CN103520531A (en) * | 2013-09-23 | 2014-01-22 | 刘兰霞 | Traditional Chinese medicinal composition for treating liver depression and qi stagnation type cholecystitis |
CN104189577A (en) * | 2014-08-27 | 2014-12-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating cholecystitis |
CN104288701A (en) * | 2014-10-17 | 2015-01-21 | 青岛市市立医院 | Traditional Chinese medicine composition for treating cholecystitis |
-
2015
- 2015-02-05 CN CN201510060111.6A patent/CN104547721A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103230566A (en) * | 2013-04-19 | 2013-08-07 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medical composition for treating cholecystitis cholelithiasis and application thereof |
CN103520531A (en) * | 2013-09-23 | 2014-01-22 | 刘兰霞 | Traditional Chinese medicinal composition for treating liver depression and qi stagnation type cholecystitis |
CN103495061A (en) * | 2013-09-25 | 2014-01-08 | 周志坚 | Traditional Chinese medicine composition for treating cholecystitis caused by stagnation of liver qi and phlegm and blood stasis |
CN104189577A (en) * | 2014-08-27 | 2014-12-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating cholecystitis |
CN104288701A (en) * | 2014-10-17 | 2015-01-21 | 青岛市市立医院 | Traditional Chinese medicine composition for treating cholecystitis |
Non-Patent Citations (1)
Title |
---|
徐永刚: "自拟金龙二黄汤治疗胆囊炎40例", 《陕西中医》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105233162A (en) * | 2015-10-30 | 2016-01-13 | 王志勇 | Traditional Chinese medicine composition for treating chronic cholecystitis, and preparation method and pharmaceuticals thereof |
CN106107036A (en) * | 2016-06-28 | 2016-11-16 | 宿松飞翔生态养殖有限公司 | A kind of livestock fodder additives with epidemic prevention function |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104547721A (en) | Traditional Chinese medicine for treating cholecystitis | |
CN103432551A (en) | Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia | |
CN101972321B (en) | Plaster for treating pains on neck, shoulder, lumbar and legs as well as traumatic injuries | |
CN101596302A (en) | A kind of treatment treating coronary heart disease and angina pectoris and preparation method thereof | |
CN104288303A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
CN103893432B (en) | It is a kind of to treat fracture, pharmaceutical composition of soft tissue injury and preparation method thereof | |
CN106138537A (en) | A kind of Chinese medicine preparation treating overall pain and preparation method thereof | |
CN103110756B (en) | Traditional Chinese medicine composition for treating renal hematuria | |
CN105853902A (en) | Plaster for treating lumbar disc herniation and preparation method thereof | |
CN103800561A (en) | Traditional Chinese medicine for treating renal hematuria | |
CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
CN105250807A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
CN105381177A (en) | External use traditional Chinese medicine for treating sweet stains | |
CN105194588A (en) | Traditional Chinese medicine preparation for treating liver cirrhosis | |
CN104688807A (en) | Traditional Chinese medicine pedicure composition and application thereof | |
CN104645224A (en) | Traditional Chinese medicine preparation for treating costal chondritis | |
CN104257972A (en) | Traditional Chinese medicine for treating child asthmatic pneumonia | |
CN102423396B (en) | Composition used for treating rheumatoid arthritis | |
CN114699363A (en) | Traditional Chinese medicine wax mud for osteoarthritis and preparation method thereof | |
CN108938763A (en) | A kind of Chinese medicine massage creme of menstruction regulating and pain relieving | |
CN102688458B (en) | Chinese medicament for treating primary dysmenorrhea | |
CN101732653B (en) | Medicament for curing senile cervical and lumbar vertebra diseases | |
CN103550300A (en) | External traditional Chinese medicine plaster for treating pain in neck, shoulders, back and legs | |
CN103263586A (en) | Traditional Chinese medicinal composition for treating mycotic enteritis | |
CN102961612A (en) | Traditional Chinese medicine capsule for treating ankylosing spondylitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150429 |
|
WD01 | Invention patent application deemed withdrawn after publication |